AXL and cancer: As a hypothetical example, pan-TAMs TKIs might be expected to target Axl on tumor cells, Mertk on infiltrating M2 macrophages, and Tyro3 on immature DCs, to collectively inhibit cancer growth, polarize macrophages and maximize antigen presentation.